41 – 50 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
- Contribution to journal › Article
- 2021
-
Mark
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
- Contribution to journal › Article
-
Mark
Postmortem Studies of Fetal Grafts in Parkinson’s Disease : What Lessons Have We Learned?
- Contribution to journal › Scientific review
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
- Contribution to journal › Article
-
Mark
Life satisfaction and adaptation in persons with Parkinson’s disease — A qualitative study
- Contribution to journal › Article
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
- Contribution to journal › Scientific review
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
- Contribution to journal › Article
-
Mark
Toxin-Based Rodent Models of Parkinson’s Disease
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation
- Contribution to journal › Article
-
Mark
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
- Contribution to journal › Article
